Previous work by Labiano and colleagues revealed that tumor cells upregulate their expression of soluble CD137 (sCD137) under hypoxic conditions as a mechanism to evade immune detection by neutralizing CD137L on APCs 31. Here, TNFRSF9 is linked to neoplasm.